02.10.2018 • NewsElaine BurridgeWestlake

Westlake Bids for French Compounder Nakan

Westlake Bids for French Compounder Nakan
Westlake Bids for French Compounder Nakan

US petrochemicals and plastics producer Westlake has made an exclusive binding offer of about $265 million in cash to buy Nakan, a French compounding business that is owned by private equity group OpenGate Capital.

The offer, which is subject to adjustment, was made so that Nakan can start consulting with French works councils prior to entering into a negotiated, mutually binding purchase agreement.

“The combination of Nakan with Westlake’s existing compounding business will present an excellent strategic fit. It will allow us to expand our compounding business globally and add important specialty products and technology to our existing portfolio,” said Albert Chao, Westlake’s president and CEO.

Headquartered in Reims, Nakan has eight production plants in France, Germany, Italy, Spain, Mexico, China, Japan and Vietnam, along with a research facility in France and an application laboratory in the US. The company had sales of around $300 million in the most recent twelve-month period.

The transaction is expected to close by early 2019, subject to regulatory approvals, completion of required employee consultation procedures and other customary closing conditions.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.